Main Article Content
plastic surgery, COVID-19, telemedicine
It is not hard to list some of the profound effects COVID-19 has had on the specialty of plastic surgery.
World-wide many of our colleagues have suffered serious illness and many have died. Even in countries like Australia and New Zealand, relatively spared from the ravages of the disease, we have all had significant disruptions to our lives and practices
Limitations on elective surgery during lockdown, reduced rates of screening for breast cancer and melanoma (Figure 1), consulting with masks—all affect our ability to provide a safe and effective service for our patients. Eminent plastic surgeons choosing to take early retirement is a great loss of institutional memory. Opportunistic governments and administrators taking advantage and using COVID-19 as an excuse to push through ‘urgent’ changes challenge our ability to provide a safe and effective service
2. Saad NH, AlQattan HT, Husain T, Ochoa O, Chrysopoulo M. Telemedicine and plastic and reconstructive surgery: lessons from the COVID-19 pandemic and directions for the future. Plast Reconst Surg. 2020;146(5):680e–683e. https://doi.org/10.1097/PRS.0000000000007344
3. Funderburk CD, Batulis NS, Zelones JT, Fisher AH, Prock KL, Markov NP, Evans AE, Nigriny JF. Innovations in the plastic surgery care pathway: using telemedicine for clinical efficiency and patient satisfaction. Plast Reconst Surg. 2019;144(2):507–16. https://doi.org/10.1097/PRS.0000000000005884 PMid:31348369